Showing results (1-10 of 177) with videos related to
Sort By:
Pageof 18
Expert Review of Clinical Immunology|December 17, 2014
Teriflunomide for the treatment of relapsing-remitting multiple sclerosisAaron E MillerTherapeutic Advances in Neurological Disorders|December 6, 2017
Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experienceAaron E MillerNeurodegenerative Disease Management|December 13, 2016
Teriflunomide in multiple sclerosis: an updateAaron E MillerNeurodegenerative Disease Management|September 6, 2021
An updated review of teriflunomide's use in multiple sclerosisAaron E MillerClinical Therapeutics|September 15, 2015
Teriflunomide: a once-daily oral medication for the treatment of relapsing forms of multiple sclerosisAaron E MillerMultiple Sclerosis (Houndmills, Basingstoke, England)|February 27, 2024
Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?Aaron E MillerThe Mount Sinai Journal of Medicine, New York|March 23, 2011
Multiple sclerosis: where will we be in 2020?Aaron E MillerContinuum (Minneapolis, Minn.)|June 5, 2016
Switching or Discontinuing Disease-Modifying Therapies for Multiple SclerosisAaron E MillerCurrent Opinion in Neurology|March 9, 2012
Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needsAaron E Miller, Robert W RhoadesPageof 18